These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9614567)
1. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting. McKie EA; Graham DI; Brown SM Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567 [TBL] [Abstract][Full Text] [Related]
2. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter. Wang CY; Wang S Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097 [TBL] [Abstract][Full Text] [Related]
3. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373 [TBL] [Abstract][Full Text] [Related]
4. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes. Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter. Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672 [TBL] [Abstract][Full Text] [Related]
6. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy. Chen J; Bezdek T; Chang J; Kherzai AW; Willingham T; Azzara M; Nisen PD Cancer Res; 1998 Aug; 58(16):3504-7. PubMed ID: 9721849 [TBL] [Abstract][Full Text] [Related]
7. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions. Sousa Vde O; Romão L; Neto VM; Gomes FC Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546 [TBL] [Abstract][Full Text] [Related]
8. GFAP promoter elements required for region-specific and astrocyte-specific expression. Lee Y; Messing A; Su M; Brenner M Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313 [TBL] [Abstract][Full Text] [Related]
9. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843 [TBL] [Abstract][Full Text] [Related]
10. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Lee Y; Su M; Messing A; Brenner M Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522 [TBL] [Abstract][Full Text] [Related]
11. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Smith-Arica JR; Morelli AE; Larregina AT; Smith J; Lowenstein PR; Castro MG Mol Ther; 2000 Dec; 2(6):579-87. PubMed ID: 11124058 [TBL] [Abstract][Full Text] [Related]
12. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease. Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667 [TBL] [Abstract][Full Text] [Related]
13. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism. Segovia J; Vergara P; Brenner M Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444 [TBL] [Abstract][Full Text] [Related]
14. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene. Vandier D; Rixe O; Brenner M; Gouyette A; Besnard F Cancer Res; 1998 Oct; 58(20):4577-80. PubMed ID: 9788604 [TBL] [Abstract][Full Text] [Related]
15. Normal and pathological expression of GFAP promoter elements in transgenic mice. Galou M; Pournin S; Ensergueix D; Ridet JL; Tchélingérian JL; Lossouarn L; Privat A; Babinet C; Dupouey P Glia; 1994 Dec; 12(4):281-93. PubMed ID: 7890332 [TBL] [Abstract][Full Text] [Related]
16. Drug inducible transgene expression in brain using a herpes simplex virus vector. Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573 [TBL] [Abstract][Full Text] [Related]
17. Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas. Fukuyama K; Matsuzawa K; Hubbard SL; Dirks PB; Murakami M; Rutka JT Anticancer Res; 1996; 16(3A):1251-7. PubMed ID: 8702246 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
19. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382 [TBL] [Abstract][Full Text] [Related]
20. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]